Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sorrento Therapeutics, Inc.

0.0021
-0.0004-16.00%
Volume:122.39K
Turnover:257.19
Market Cap:1.14M
PE:0.00
High:0.0021
Open:0.0021
Low:0.0021
Close:0.0025
Loading ...
Jun 04, 2021

Major Issues Report

8-K - Current report
Jun 02, 2021

Major Issues Report

8-K - Current report
May 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 05, 2021

Major Issues Report

8-K - Current report
Apr 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 10, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 19, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Major Issues Report

8-K - Current report